Please assess the completion status of the following clinical trial:

Trial Title: Glycemic Control to Prevent Cardiac Morbidity in Vascular Surgery

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Abdominal aortic surgery~* Supra and infrainguinal peripheral vascular bypass surgery~* Below knee amputations~* Above knee amputations~* Diabetics and nondiabetics~* American Society of Anesthesiologists (ASA) I-III~Exclusion Criteria:~* Brittle diabetics~* ASA 1V,V~* Second surgery in same admission

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- CII, Continuous Insulin Infusion (Type: EXPERIMENTAL): Continuous intravenous insulin infusion to control glucose to \<150 mg/dL in patients undergoing open peripheral vascular bypass surgery
- IIB, Intermittent insulin boluses (Type: ACTIVE_COMPARATOR): Intermittent intravenous insulin insulin boluses to a blood glucose target of \<150mg/dL in patients undergoing peripheral vascular bypass surgery

Based on this trial design, predict the completion outcome and termination type (if applicable).